Michael McDonnell - IQVIA Holdings Insider

Q -- USA Stock  

USD 103.48  0.57  0.55%

CFO, Executive Vice President

Mr. Michael R. McDonnell is a Executive Vice President, Chief Financial Officer of the Company., effective December 2015. Prior to joining us, he was the Executive Vice President and Chief Financial Officer of Intelsat, a leading global provider of satellite services, from November 2008 until December 2015. He was previously Executive Vice President, Chief Financial Officer and Treasurer of MCG Capital Corporationrationration, a publiclyheld commercial finance company, from September 2004 and its Chief Operating Officer from August 2006 through October 2008. From August 2000 to August 2004, Mr. McDonnell was employed by EchoStar Communications Corporationrationration, a directtohome satellite television operator, where he served as Executive Vice President and Chief Financial Officer from July 2004 to August 2004 and as Senior Vice President and Chief Financial Officer from August 2000 to July 2004. Prior to joining EchoStar, from 1986 to 2000 Mr. McDonnell was employed by PricewaterhouseCoopers LLP, where he was a partner from 1996. He also served on the board of directors of Catalyst Health Solutions, Inc., a pharmacy benefit management company, from 2005 to 2012
Age: 52  President Since 2015      
919-998-2000  www.quintiles.com
McDonnell has a BS degree in accounting from Georgetown University and is a certified public accountant.

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. IQVIA Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives


Roger BirdAbbott Laboratories
Reshma KewalramaniVertex Pharmaceuticals Incorpor
Paul SilvaVertex Pharmaceuticals Incorpor
Daniel SalvadoriAbbott Laboratories
Jared WatkinAbbott Laboratories
Louis SchmuklerBristol Myers Squibb Company
Daniel RudioEndo International plc
Richard DeLucaMerck Co
Barton PetersonEli Lilly and Company
Michael PartridgeVertex Pharmaceuticals Incorpor
Ronald HuttonBio Rad Laboratories
Brian LortieEndo International plc
Hugh ONeillMallinckrodt Public Limited Com
Mirian GraddickWeirMerck Co
Jeffrey SimmonsEli Lilly and Company
Shawn SoderbergBio Rad Laboratories
Alfonso ZuluetaEli Lilly and Company
Ian SmithVertex Pharmaceuticals Incorpor
Blaise ColemanEndo International plc
Camille FarhatEndo International plc
Steve RomanoMallinckrodt Public Limited Com

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. IQVIA Holdings (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

IQVIA Holdings Leadership Team

Thomas Pike, CEO
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Richard Staub, President
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Ronald Rittenmeyer, Director, MBA
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Kevin Knightly, President

Stock Performance Indicators

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Portfolio Manager

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
few days ago
Traded for 10.44
Purchased over 300 shares of
few days ago
Traded for 6.24
Purchased over 70 shares of
few days ago
Traded for 23.42
Purchased over 200 shares of
few days ago
Traded for 8.1
Purchased over 400 shares of
few days ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.